A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults.

Carey, Dianne; Pett, Sarah L; Bloch, Mark; Wand, Handan; MacRae, Karen; Beileiter, Kate; Ray, John E; Boyd, Mark A; Emery, Sean; Cooper, David A

Carey, Dianne; Pett, Sarah L; Bloch, Mark; Wand, Handan; MacRae, Karen; Beileiter, Kate; Ray, John E; Boyd, Mark A; Emery, Sean; Cooper, David A.

Affiliation

Carey D; Kirby Institute/University of New South Wales, Sydney, Australia. dcarey@kirby.unsw.edu.au

J Acquir Immune Defic Syndr ; 60(2): 143-9, 2012 Jun 01.

Article in En | MEDLINE | ID: mdl-22421745

Subject(s)

Anti-HIV Agents/administration & dosage; Antiretroviral Therapy, Highly Active/methods; HIV Infections/drug therapy; Oligopeptides/administration & dosage; Pyridines/administration & dosage; Pyrrolidinones/administration & dosage; Adult; Anti-HIV Agents/adverse effects; Anti-HIV Agents/pharmacokinetics; Antiretroviral Therapy, Highly Active/adverse effects; Atazanavir Sulfate; Drug-Related Side Effects and Adverse Reactions/epidemiology; Humans; Male; Middle Aged; Oligopeptides/adverse effects; Oligopeptides/pharmacokinetics; Plasma/chemistry; Pyridines/adverse effects; Pyridines/pharmacokinetics; Pyrrolidinones/adverse effects; Pyrrolidinones/pharmacokinetics; Raltegravir Potassium; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Pyrrolidinones / HIV Infections / Anti-HIV Agents / Antiretroviral Therapy, Highly Active Type of study: Clinical_trials Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2012 Document type: Article Affiliation country: Australia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google